SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

<Table>

[ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission
[X] Definitive Proxy Statement Only (as permitted by Rule 14a-6(e)(2))
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-2.
</Table>

HEALTH MANAGEMENT SYSTEMS, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)

- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-12.

(1) Title of each class of securities to which transaction applies:

------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:

------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:

------------------------------------------------------------------------
(5) Total fee paid:

------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:

------------------------------------------------------------------------
(3) Filing Party:

------------------------------------------------------------------------
(4) Date Filed:

------------------------------------------------------------------------

HEALTH MANAGEMENT SYSTEMS, INC.
401 PARK AVENUE SOUTH
NEW YORK, NEW YORK 10016

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD JUNE 4, 2002

The Annual Meeting of Shareholders (the "Meeting") of Health Management
Systems, Inc. (the "Company") will be held at the offices of the Company, 401
Park Avenue South, New York, New York, on June 4, 2002 at 11:00 a.m., Eastern
Daylight Time, for the following purposes:

1. To elect three directors to serve for two-year terms expiring at
the annual meeting in 2004 and until their successors are elected and
qualified;

2. To consider and to take action on the approval of an award of
options to purchase shares of Company common stock to Mr. James T. Kelly;

3. To consider and to take action on the ratification of amendments to
the Company's 1999 Long-Term Incentive Stock Plan;

4. To consider and take action on the ratification of the selection of
KPMG LLP as the Company's independent certified public accountants for
fiscal year 2002; and

5. To transact such other business as may properly come before the
Meeting or any adjournments thereof.

Only shareholders of record at the close of business on April 17, 2002 will
be entitled to receive notice of and to vote at the Meeting.

Shareholders are cordially invited to attend the Meeting in person. Whether
or not you expect to attend, WE URGE YOU TO READ THE ACCOMPANYING PROXY
STATEMENT AND THEN COMPLETE, SIGN, DATE, AND RETURN THE ENCLOSED FORM OF PROXY
IN THE ACCOMPANYING POSTAGE-PREPAID ENVELOPE. It is important that your shares
be represented at the Meeting by virtue of your executed proxies should you be
unable to attend the Meeting in person. Your promptness in responding will
assist us to prepare for the Meeting and to avoid the cost of a follow-up
mailing. If you receive more than one form of proxy because you own shares
registered in different names or at different addresses, each form of proxy
should be completed and returned.

Sincerely,

/s/ KATHY L. ARENDT
Kathy L. Arendt
Secretary

April 30, 2002

HEALTH MANAGEMENT SYSTEMS, INC.
401 PARK AVENUE SOUTH
NEW YORK, NEW YORK 10016

PROXY STATEMENT

ANNUAL MEETING OF SHAREHOLDERS TO BE HELD JUNE 4, 2002

GENERAL INFORMATION

This Proxy Statement is furnished to shareholders of Health Management
Systems, Inc., a New York corporation (the "Company"), in connection with the
solicitation by the Board of Directors of the Company of proxies for use at its
Annual Meeting of Shareholders (the "Meeting"). The Meeting is scheduled to be
held on Tuesday, June 4, 2002, at 11:00 a.m., Eastern Daylight Time, at the
offices of the Company, 401 Park Avenue South, New York, New York, and at any
adjournments thereof. It is anticipated that this Proxy Statement and the
enclosed form of proxy will be mailed to shareholders on or about April 30,
2002.

At the Meeting, shareholders will be asked to vote upon: (1) the election
of three directors; (2) the approval of an award of options to purchase shares
of Company Common Stock to Mr. James T. Kelly; (3) the ratification of
amendments to the Company's 1999 Long-Term Incentive Stock Plan; (4) the
ratification of the selection of independent certified public accountants for
fiscal year 2002; and (5) such other business as may properly come before the
Meeting and at any adjournments thereof.

VOTING RIGHTS AND VOTES REQUIRED

The close of business on April 17, 2002 has been fixed as the record date
(the "Record Date") for the determination of shareholders entitled to receive
notice of and to vote at the Meeting. As of the close of business on such date,
the Company had outstanding and entitled to vote 18,159,373 shares of common
stock, par value $0.01 per share (the "Common Stock").

A majority of the shares of Common Stock entitled to vote at the meeting
must be represented in person or by proxy at the Meeting in order to constitute
a quorum for the transaction of business. The record holder of each share of
Common Stock entitled to vote at the Meeting will have one vote for each share
so held.

Directors are elected by a plurality of the votes cast. Shareholders may
not cumulate their votes. The three candidates receiving the highest number of
votes will be elected. In tabulating the votes, votes withheld in connection
with the election of one or more nominees and broker nonvotes will be
disregarded and will have no effect on the outcome of the vote.

The affirmative vote of the holders of a majority of the shares of Common
Stock represented at the Meeting in person or by proxy and entitled to vote
thereat will be required to approve the grant of options to Mr. Kelly, to ratify
the amendments to the 1999 Long-Term Incentive Plan and to ratify the selection
of the Company's independent certified public accountants. In determining
whether these proposals have received the requisite number of affirmative votes,
abstentions and broker nonvotes will be disregarded and will have no effect on
the outcome of the vote, although they will count for quorum purposes.

VOTING OF PROXIES

If the accompanying proxy is properly executed and returned, the shares
represented by the proxy will be voted at the Meeting as specified in the proxy.
If no instructions are specified, the shares represented by any

properly executed proxy will be voted FOR the election of the nominees listed
below under "Election of Directors", FOR the approval of the option award to Mr.
James T. Kelly, FOR the ratification of proposed amendments to the Company's
1999 Long-term Incentive Stock Plan, and FOR the ratification of the selection
of independent certified public accountants.

REVOCATION OF PROXIES

Any proxy given pursuant to this solicitation may be revoked by a
shareholder at any time before it is exercised by: (i) written notice to the
Secretary of the Company, (ii) timely notice of a properly executed proxy
bearing a later date delivered to the Company, or (iii) voting in person at the
Meeting.

SOLICITATION OF PROXIES

The Company will bear the cost of this solicitation, including amounts paid
to banks, brokers, and other record owners to reimburse them for their expenses
in forwarding solicitation materials regarding the Meeting to beneficial owners
of Common Stock. The solicitation will be by mail, with the materials being
forwarded to shareholders of record and certain other beneficial owners of
Common Stock by the Company's officers and other regular employees (at no
additional compensation). Such officers and employees may also solicit proxies
from shareholders by personal contact, by telephone, or by other means if
necessary in order to assure sufficient representation at the Meeting.

Mellon Investor Services L.L.C. has been retained to receive and tabulate
proxies and to provide representatives to act as inspectors of election for the
Meeting.

MATTERS SUBJECT TO SHAREHOLDER VOTE

1. ELECTION OF DIRECTORS

Pursuant to the Company's by-laws, the Board of Directors of the Company is
currently divided into two classes, with one class standing for election each
year for two-year terms. The terms of three directors, including one director
appointed to replace a director who resigned at the end of calendar year 2001,
will expire at the Meeting. Accordingly, the term of the three nominees listed
below, if elected at the Meeting, will expire at the 2004 annual meeting. The
terms of the other current directors listed below will expire at the 2003 annual
meeting.

The three persons designated by the Board of Directors as nominees for
election as directors with terms expiring at the 2004 annual meeting are
Randolph G. Brown, James T. Kelly and Galen D. Powers.

Unless a contrary direction is indicated, it is intended that proxies
received will be voted for the election as directors of the three nominees to
serve for two-year terms expiring at the 2004 annual meeting, and in each case
until their successors are elected and qualified. In the event any nominee for
director declines or is unable to serve, the proxies may be voted for a
substitute nominee selected by the Board of Directors. The Board of Directors
expects that each nominee named in the following table will be available for
election.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR ALL NOMINEES.

<Table>
<Caption>
SERVED AS
DIRECTOR
NAME POSITION WITH THE COMPANY OR PRINCIPAL OCCUPATION FROM
- ---- ------------------------------------------------- ---------

Nominees for directors for two-year terms ending in 2004:
Randolph G. Brown...................... Private Investor. Formerly Chairman and Chief 1998
Executive Officer of One Inc., a surgery center
management company.
James T. Kelly......................... Private Investor. Director of American Dental 2001
Partners, Inc. and Ameripath, Inc. Formerly
Chairman of the Board and Chief Executive Officer
of Lincare Holdings, Inc., a provider of oxygen
and respiratory therapy services to patients in
the home.
Galen D. Powers........................ Senior Founder of Powers, Pyles, Sutter & 1992
Verville, P.C., a healthcare law firm; Director of
MedCath, which owns and operates acute care
hospitals that specialize in cardiovascular
disease.
Directors continuing in office until 2003:
William F. Miller III.................. Chairman and Chief Executive Officer of the 2000
Company.
William W. Neal........................ Affiliate of Piedmont Venture Partners and 1989
Carolina Financial Group, venture capital firms.
Ellen A. Rudnick....................... Executive Director, Entrepreneurship Program, 1997
University of Chicago Graduate School of Business.
Richard H. Stowe....................... Private Investor. Senior Advisor to Capital 1989
Counsel LLC, an asset management firm.
</Table>

EXECUTIVE OFFICERS AND DIRECTORS

Certain information is set forth below with respect to the executive
officers and directors of the Company as of April 17, 2002:

<Table>
<Caption>
NAME POSITION
- ---- --------

William F. Miller III.................. Chairman and Chief Executive Officer
Robert M. Holster...................... President and Chief Operating Officer
Philip Rydzewski....................... Senior Vice President and Chief Financial Officer
William C. Lucia....................... President, Payor Services Division
Randolph G. Brown...................... Director
James T. Kelly......................... Director
William W. Neal........................ Director
Galen D. Powers........................ Director
Ellen A. Rudnick....................... Director
Richard H. Stowe....................... Director
</Table>

WILLIAM F. MILLER III, 52, Chairman and Chief Executive Officer, joined the
Company in October 2000 as Chief Executive Officer and director. On December 14,
2000, Mr. Miller was elected Chairman of the Board. From 1983 through 1999, Mr.
Miller served as President and Chief Operating Officer of EmCare Holdings, Inc.,
a leading national healthcare services firm that was acquired in 1997 by
Laidlaw, Inc. From 1980 through 1983, Mr. Miller served as Administrator and
Chief Operating Officer of Vail Mountain Medical. Prior to 1980, Mr. Miller
served in various capacities at various hospital facilities. Mr. Miller is
currently a director of LinCare, Inc. and AMN Healthcare, Inc.

ROBERT M. HOLSTER, 55, joined the Company in April of 2001 as President and
Chief Operating Officer. From 1993 through 1998, Mr. Holster served as President
and Chief Executive Officer of HHL Financial Services, Inc., at the time one of
the nation's largest healthcare accounts receivable management companies. From
1998 to 2000, Mr. Holster served as Trustee of the HHL Trust. Previously, Mr.
Holster served as Executive Vice President of the Company from 1982 through 1993
and as a Director of the Company from 1989 through 1996. Prior to 1982, Mr.
Holster served in a number of executive positions including Chief Financial
Officer of Macmillan, Inc. and Controller of Pfizer Laboratories, a Division of
Pfizer, Inc.

PHILIP RYDZEWSKI, 39, Senior Vice President and Chief Financial Officer,
joined the Company in April 2001 as Vice President and Controller. Previously,
from 1990 until 1998, he was Vice President Finance and Corporate Controller for
PHP Healthcare Corporation, a publicly held diversified healthcare services
provider. Prior to that, from 1985 to 1990, Mr. Rydzewski was in the auditing
and accounting services practice with KPMG LLP. Most recently, during 1999 and
2000, Mr. Rydzewski served as Vice President of Finance for a venture capital
backed start-up firm, and provided merger and acquisition and business financial
consulting services for several publicly held technology and consulting firms.

WILLIAM C. LUCIA, 44, President, Payor Services Division, joined the
Company in 1996. Mr. Lucia has held several positions with the Company
including: Vice President and General Manager, Payor Services Division, 2000 to
2001; Vice President, Business Office Services, 1999 to 2000; Chief Operating
Officer of Quality Medi-Cal Adjudications, Inc. ("QMA") (a wholly owned
subsidiary of the Company) and Vice President of West Coast Operations, 1998 to
1999; Vice President and General Manager of QMA, 1997 to

1998; and Director of Information Systems for QMA, 1996 to 1997. Prior to
joining the Company, Mr. Lucia served in various executive positions including
Senior Vice President, Operations and Chief Information Officer for Celtic Life
Insurance Company and Senior Vice President, Insurance Operations for North
American Company for Life and Health Insurance. Mr. Lucia is a Fellow, Life
Management Institute (LOMA).

RANDOLPH G. BROWN, 59, was appointed a director of the Company in May 1998.
Mr. Brown is a private investor who formerly served as Chairman and Chief
Executive Officer of One-Inc., a developer and manager of refractive and
cataract surgery centers in New York, from August of 1999 until he sold the
business in October 2001. Previously, Mr. Brown had been an independent business
consultant since November 1996, principally as a venture partner with
Morgenthaler Venture Partners. From July 1987 through October 1996, Mr. Brown
served in various senior executive positions, including Chairman, President and
Chief Executive Officer for Medaphis Corporation, a provider of accounts
receivable management services to hospital-affiliated physicians and hospitals.
From 1978 to 1987, Mr. Brown served in various management positions with Humana
Inc., at that time a provider of integrated healthcare delivery services.

JAMES T. KELLY, 55, was appointed director of the Company in December of
2001. Mr. Kelly served as the Chief Executive Officer of Lincare Holdings, Inc.,
one of the nation's largest providers of oxygen and other respiratory therapy
services to patients in the home, from 1986 through 1996, and served as Chairman
of the Board from 1994 through 2000. Prior to becoming Lincare's Chief Executive
Officer, Mr. Kelly served in a number of positions within the Mining and Metals
Division of Union Carbide Corporation. Mr. Kelly is currently a director of
American Dental Partners, Inc., Ameripath and several private companies.

WILLIAM W. NEAL, 70, has served as a director of Health Management Systems,
Inc. since 1989. Mr. Neal has been affiliated with Piedmont Venture Partners, a
venture capital firm, since July 1996 and is also currently affiliated with the
Carolina Financial Group, a venture capital firm. From 1989 to 1996, he served
as Chief Executive officer of Broadway and Seymour, a company that provides
software and computer systems to the banking industry. From 1985 through July
1989, he was a general partner of Welsh, Carson, Anderson & Stowe ("WCAS"), an
investment firm. Mr. Neal was Senior Vice President, Marketing of Automated Data
Processing, Inc. ("ADP") from 1984 to 1985 and a Group President of ADP from
1978 to 1984. He served as a director of ADP from 1982 to 1985.

GALEN D. POWERS, 65, a director since 1992, is the Senior Founder of
Powers, Pyles, Sutter & Verville P.C., a Washington, D.C. law firm specializing
in healthcare and hospital law, which he founded in 1983. Mr. Powers was the
first chief counsel of the federal Health Care Financing Administration (now
Centers for Medicare and Medicaid Services) and has served as a director and the
President of the American Health Lawyers Association. Mr. Powers is currently a
director of MedCath, Inc., which owns and operates acute care hospitals that
specialize in cardiovascular disease.

ELLEN A. RUDNICK, 51, a director since 1997, is the Executive Director and
Clinical Professor of the Entrepreneurship Program at the University of Chicago
Graduate School of Business. She also serves as Chairman of CEO Advisors, Inc.,
a privately held consulting firm. From 1993 until 1999, Ms. Rudnick served as
Chairman of Pacific Biometrics, Inc., a publicly held healthcare biodiagnostics
company and its predecessor, Bioquant. From 1990 to 1992, she was President and
Chief Executive Officer of Healthcare Knowledge Resources ("HKR"), a privately
held healthcare information technology corporation, and subsequently served as
President of HCIA, Inc. ("HCIA") following the acquisition of HKR by HCIA. From
1975 to 1990, Ms. Rudnick served in various positions at Baxter Health Care
Corporation, including

Corporate Vice President and President of its Management Services Division. She
also serves on the Boards of Liberty Mutual Insurance Company and Oxford Health
Plans.

RICHARD H. STOWE, 58, has served as a director since 1989. Mr. Stowe is a
private investor and Senior Advisor to Capital Counsel LLC, an asset management
firm. From 1979 until 1998, Mr. Stowe was a general partner of WCAS. Prior to
1979, he was a Vice President in the venture capital and corporate finance
groups of New Court Securities Corporation (now Rothschild, Inc.). Mr. Stowe is
also a director of MedQuist, Inc. a provider of medical record transcription
services.

DIRECTORS' FEES

Non-employee directors are paid $1,500 for each regularly scheduled Board
of Directors meeting, $500 for each regularly scheduled committee meeting, and
$250 for each special Board of Directors or committee meeting which they attend,
and are reimbursed for expenses incurred in attending meetings.

On December 15, 2000, William W. Neal, Ellen A. Rudnick, and Galen D.
Powers were each granted options under the Company's 1999 Long-Term Incentive
Stock Plan to purchase 25,000 shares of Common Stock, at an exercise price of
$1.07 per share (the fair market value of the Common Stock on such date). The
options vest one-third on the date of grant and one-third thereafter annually on
the anniversary date. In addition, on December 15, 2000, Richard H. Stowe and
Randolph G. Brown were each granted options under the Company's 1999 Long-Term
Incentive Stock Plan to purchase 150,000 shares of Common Stock, at an exercise
price of $1.07 per share (the fair market value of the Common Stock on such
date). The options vest as follows: 30,000 shares on the date of grant, 45,000
shares on the first anniversary, and the remaining 75,000 shares thereafter in
eight equal quarterly installments. This grant represented 25,000 options for
service as Board members consistent with the grant above made to the other
outside directors, 25,000 options for additional Board member service for
participation in the Company's strategic review, divestiture assessment and
operational re-engineering, and 100,000 options for additional consulting
service beyond their status as Board members for participation in the Company's
strategic review, divestiture assessment and operational re-engineering.

On December 12, 2001, William W. Neal, Ellen A. Rudnick, Galen D. Powers,
Richard H. Stowe and Randolph G. Brown were each granted options under the
Company's 1999 Long-Term Incentive Stock Plan to purchase 60,000 shares of
Common Stock, at an exercise price of $2.48 per share (the fair market value of
the Common Stock on such date). The options vest one-third on the date of grant
and one-third annually thereafter on the anniversary date of the grant. It is
anticipated that the non-employee directors of the Board will not be granted
additional options under the Company's Plan until the current vesting schedule
is completed in 2003.

COMMITTEES AND MEETINGS OF THE BOARD OF DIRECTORS

The Board of Directors held six meetings during fiscal year 2001 and one
meeting during the transition period. Each director attended at least 75% of the
aggregate of the total number of meetings of (a) the Board of Directors, and (b)
the committees on which the director served.

The committees of the Board of Directors consist of an Audit and Compliance
Committee and a Compensation Committee.

AUDIT AND COMPLIANCE COMMITTEE. The Audit and Compliance Committee
recommends to the Board of Directors the annual appointment of independent
certified public accountants with whom the Committee

reviews audit fees, the scope and timing of the audit, the adequacy of internal
controls, and any other services rendered. The functions of the Audit and
Compliance Committee also include review of corporate compliance and related
matters. The Audit and Compliance Committee is comprised of Messrs. Powers,
Brown and Stowe. The Audit and Compliance Committee held four meetings during
fiscal year 2001 and two meetings during the transition period.

COMPENSATION COMMITTEE. The Compensation Committee reviews and recommends
the compensation and bonuses of the executives of the Company. The Compensation
Committee also administers the Company's 1999 Long-Term Incentive Stock Plan,
Employee Stock Purchase Plan, and 1995 Non-Employee Director Stock Option Plan.
The Compensation Committee is comprised of Messrs. Neal and Stowe and held one
meeting during fiscal year 2001 and one meeting during the transition period.

COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT OF 1934

Pursuant to Section 16(a) of the Securities Exchange Act of 1934 (the
"Exchange Act") and the rules issued thereunder, the Company's executive
officers and directors are required to file with the Securities and Exchange
Commission and the National Association of Securities Dealers, Inc. reports of
ownership and changes in ownership of Common Stock. Copies of such reports are
required to be furnished to the Company. Based solely on review of the copies of
such reports furnished to the Company, or written representations that no other
reports were required, the Company believes that during fiscal year 2001 all of
its executive officers and directors complied with the requirements of Section
16(a), except William W. Neal, a director of the Company, did not timely report
the acquisition of 4,000 shares of Common Stock in September 2001 and the
acquisition of 1,000 shares of Common Stock in October 2001 by his spouse.

ADDITIONAL INFORMATION REGARDING COMPENSATION OF EXECUTIVE OFFICERS AND
DIRECTORS IS PROVIDED ON PAGES 17 THROUGH 21 OF THIS PROXY STATEMENT.

2. APPROVAL OF THE GRANT OF A STOCK OPTION TO JAMES T. KELLY

As an inducement to James T. Kelly to serve on the Company's Board of
Directors, the Board of Directors undertook to seek shareholder approval at the
Meeting of a grant of options to him to acquire 250,000 shares of Common Stock.
Accordingly, the Board of Directors is recommending that the shareholders
approve the grant to Mr. Kelly of options covering 250,000 shares of Common
Stock at an exercise price of $2.48 per share, which was the fair market value
of a share of Common Stock on December 12, 2001, the date Mr. Kelly joined the
Board. The options would vest in their entirety on the proposed grant date of
June 4, 2002. The grant of the options is conditioned upon shareholder approval
of the options at the Meeting. The grant of the options is further conditioned
upon the shareholders electing Mr. Kelly to the Board at the Meeting. If
approved by the shareholders these options will be considered compensatory and
will result in a compensation charge of approximately $1.0 million on the date
of grant. These options will be granted outside of the Company's 1999 Long-Term
Incentive Stock Plan.

The Board of Directors believes that Mr. Kelly will provide invaluable
industry expertise and executive leadership to the Board. He has over 20 years
experience in the healthcare industry, including service from 1986 through 1996
as the Chief Executive Officer of Lincare Holdings, Inc., one of the nation's
largest providers of oxygen and other respiratory therapy services to patients
in the home. Prior to Lincare, Mr. Kelly served in several executive positions
with Union Carbide Corporation in the Mining and Metals Division.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR APPROVAL OF THE
GRANT OF THE OPTIONS TO MR. KELLY.
7

3. PROPOSED AMENDMENT TO 1999 LONG-TERM INCENTIVE STOCK PLAN

Subject to the approval of shareholders, the Board of Directors has amended
the Company's 1999 Long-Term Incentive Stock Plan (the "1999 Plan") as follows:

- The number of shares of Common Stock available for issuance under the
1999 Plan has been increased from 4,751,356 shares to 6,251,356 shares,
an increase of 1,500,000 shares;

- The maximum number of shares for which awards may be granted to any one
participant in any fiscal year has been increased from 150,000 to 300,000
shares.

The Board of Directors believes that the best interests of the Company will
be served by adopting these amendments to the 1999 Plan. The Board of Directors
believes awards made under the 1999 Plan have enabled the Company to better
compete for qualified personnel, to retain such personnel in the employ of the
Company, and to motivate such personnel and align their long-term interests with
those of shareholders. To remain competitive in attracting and retaining
qualified employees and to continue to provide such employees proper motivation
and incentive, the Board of Directors believes that the proposed amendments
increasing the number of shares available under the 1999 Plan and the maximum
number of shares for which awards may be granted to any one participant in any
calendar year should be approved.

In addition, shareholder approval of these amendments will constitute
approval of the amended terms of the 1999 Plan, and reapproval of the
performance criteria upon which performance-based awards that are intended to be
deductible by the Company under Section 162(m) of the Internal Revenue Code of
1986 (the "Code") may be used under the 1999 Plan. Where the Compensation
Committee has authority to change the performance criteria, this reapproval is
required every five years in order for such awards to continue to be treated as
qualified performance-based compensation under Section 162(m) of the Code and
therefore to be fully deductible by the Company.

SHARES SUBJECT TO THE 1999 PLAN

In 1999, the shareholders adopted the 1999 Plan and authorized 4,751,356
shares for award thereunder. As of March 31, 2002, 743,201 of those shares
remained available for award.

The proposed additional 1,500,000 newly authorized shares on which options
can be awarded under the 1999 Plan represent approximately 8.3% of the shares of
the Company's currently outstanding Common Stock.

DESCRIPTION OF THE 1999 PLAN

GENERAL

Under the 1999 Plan, the Company may grant stock options, stock
appreciation rights ("SARs"), or stock awards, as discussed in greater detail
below. Awards may be granted singly, in combination, or in tandem and may be
evidenced by an agreement that sets forth the terms, conditions, and limitations
of such award. Awards may also be made in combination or in tandem with, in
replacement of, as alternatives to, or as the payment form for, grants or rights
under any other compensation plan of the Company, including the plan of any
entity acquired by (or whose assets are acquired by) the Company. Reference is
made to Exhibit A to this Proxy Statement for the complete text of the 1999
Plan, as proposed to be amended, which is summarized below.

All employees of the Company and its subsidiaries are eligible to
participate in the 1999 Plan. Currently, 146 employees participate in the 1999
Plan.

ADMINISTRATION

The 1999 Plan is administered by the Compensation Committee of the Board of
Directors (the "Committee"), which Committee consists of at least two members,
all of whom are "Non-Employee Directors" within the meaning of Rule 16b-3 under
the Exchange Act and "outside directors" within the meaning of Section 162(m) of
the Code.

The 1999 Plan is intended to provide participants with stock-based
incentive compensation that is not subject to the deduction limitations under
Section 162(m) of the Code. Section 162(m) of the Code generally limits to $1
million the amount that a publicly held corporation is allowed each year to
deduct for the compensation paid to its chief executive officer and four most
highly compensated executive officers other than the chief executive officer.
However, "qualified performance-based compensation" is not subject to the $1
million deduction limit. To qualify as qualified performance-based compensation,
the following requirements must be satisfied: (i) the performance goals are
determined by a committee consisting solely of two or more "outside directors;"
(ii) the material terms under which the compensation is to be paid, including
the performance criteria, are approved by a majority of the corporation's
shareholders; and (iii) if applicable, the committee certifies that the
applicable performance goals were satisfied before payment of any performance-
based compensation is made. In the case of stock options and stock appreciation
rights, the compensation is deemed to satisfy the IRS requirements if the grant
or award is made by the compensation committee; the plan under which the option
or right is granted states the maximum number of shares with respect to which
options or rights may be granted during a specified period to any employee; and,
under the terms of the option or right, the amount of compensation the employee
could receive is based solely on an increase in the value of the stock after the
date of the grant or award. Certain of the awards made under the 1999 Plan (such
as stock options offered at fair market value) will meet these tests; others
(such as stock awards) will rely on the more general rules for qualified
performance-based compensation in order to not be subject to the $1 million
limitation. As noted above, the Committee will consist solely of "outside
directors" for purposes of Section 162(m) of the Code. As a result, and based on
regulations issued by the United States Department of the Treasury, certain
compensation under the 1999 Plan, such as that payable with respect to stock
options and SARs, is not expected to be subject to the $1 million deduction
limit, but other compensation payable under the 1999 Plan, such as any
restricted stock award which is not subject to a performance condition to
vesting, may be subject to such limit.

Subject to the express provisions of the 1999 Plan, the Committee has broad
authority to administer and interpret the 1999 Plan as it deems necessary and
appropriate. This authority includes, but is not limited to, selecting award
recipients, establishing award terms and conditions, adopting procedures and
regulations governing awards, and making all other determinations necessary or
advisable for the administration of the 1999 Plan. The Committee may provide for
the transferability of an award, including transfers to immediate family members
of a participant. Except with respect to grants to persons who are subject to
Section 16 of the Exchange Act, or who are or are likely to be "covered
employees" within the meaning of Section 162(m) of the Code, the Committee may
delegate some or all of its authority to administer the 1999 Plan to the
Chairman and Chief Executive Officer or another executive officer of the
Company.

AVAILABLE SHARES

The 1999 Plan, as proposed to be amended, authorizes the issuance, in the
aggregate, of up to 6,251,356 shares, provided, that the number of shares
subject to awards granted in substitution of awards issued by an entity acquired
by (or whose assets are acquired by) the Company will not reduce the number of
shares available under the 1999 Plan. To the extent shares subject to
outstanding awards under the 1999 Plan are not issued by reason of the
expiration, termination, cancellation, or forfeiture of such award or by reason
of the tendering or withholding of shares of Common Stock to pay all or a
portion of the purchase price, or to satisfy all or a portion of the tax
withholding obligations relating to such award, and to the extent shares
acquired pursuant to the exercise of an option or other award are repurchased by
the Company, then such shares of Common Stock will again be available under the
1999 Plan. In the event of a stock dividend, stock split, merger, consolidation,
recapitalization, spin-off, or other similar change or event, the number of
available shares may be adjusted, as the Committee in its discretion deems
appropriate.

If the proposed amendments to the 1999 Plan are approved, the maximum
number of shares of Common Stock for which awards may be granted to any person
in any fiscal year will be 300,000 shares.

EFFECTIVE DATE, TERMINATION AND AMENDMENT

If approved by shareholders, the proposed amendments to the 1999 Plan will
become effective as of the date of such approval. No stock options, SARs or
other awards may be granted under the 1999 Plan after January 10, 2009, which is
the day before the tenth anniversary of the date of the original adoption of the
1999 Plan by the Board of Directors. The Board of Directors may amend the 1999
Plan at any time, subject to any requirement of shareholder approval required by
applicable law, rule, or regulation and provided that no amendment may be made
without shareholder approval if such amendment would (i) increase the maximum
number of shares of Common Stock available under the 1999 Plan or (ii) effect
any change inconsistent with Section 422 of the Code.

STOCK OPTIONS

A stock option represents the right to purchase a specified number of
shares of Common Stock during a specified period, typically up to ten years, as
determined by the Committee. The purchase price per share for each stock option
may not be less than 100% of the fair market value on the date of grant;
provided that a stock option granted in substitution of an award granted by an
entity acquired by (or whose assets are acquired by) the Company may be granted
with a purchase price that preserves the economic value of the award and with
respect to a stock option granted retroactively in substitution for an option or
SAR, the purchase price per share may be the fair market value on the grant date
of the option or SAR. A stock option may be in the form of an incentive stock
option or a non-qualified stock option. In the case of an incentive stock option
granted to an optionee who, at the time of grant, owns stock possessing more
than 10% of the total combined voting power of all classes of stock of the
Company or its parent or subsidiaries, as defined in the Code, the exercise
price per share may not be less than 110% of the fair market value on the date
of grant and the option may not be exercisable more than five years after the
date granted. The shares covered by a stock option may be purchased, in
accordance with the applicable award agreement, by cash payment or other method
permitted by the Committee, including (i) tendering shares of Common Stock, (ii)
authorizing third party exercise transactions, or (iii) any combination of the
above.

SARS

An SAR represents a right to receive a payment, in cash, shares of Common
Stock, or a combination thereof, equal to the excess of the fair market value of
a specified number of shares of Common Stock on the date the SAR is exercised
over the fair market value of such shares on the date the SAR was granted.
However, if an SAR is granted retroactively in substitution for a stock option,
the fair market value may be the fair market value on the date the stock option
was granted. The Committee may grant SARs alone or together with stock options.
The Committee has not awarded SARs in the past and has no current intention of
making this type of award in the future.

STOCK AWARDS

A stock award represents an award made in or valued, in whole or in part,
by reference to shares of Common Stock. All or part of a stock award may be
payable in shares of Common Stock and may be subject to conditions and
restrictions established by the Committee. Such conditions may include, but are
not limited to, continuous service with the Company and its subsidiaries and/or
the achievement of performance goals. The performance criteria that may be used
by the Committee in granting stock awards contingent on performance goals
consist of total shareholder return, net sales, operating income, income before
taxes, net income, net income per share (basic or diluted), profitability as
measured by return ratios, including return on invested capital, return on
equity and return on investment, cash flows, market share, or cost reduction
goals. The Committee may select one criterion or multiple criteria for measuring
performance, and the measurement may be based on Company or business unit
performance, or on comparative performance with other companies. The Committee
has not granted stock awards in the past and has no current intention of making
this type of award in the future.

FEDERAL INCOME TAX CONSEQUENCES

The following is a brief summary of certain federal income tax consequences
generally arising with respect to awards under the 1999 Plan.

A participant will not recognize taxable income at the time a stock option
is granted and the Company will not be entitled to a tax deduction at such time.
A participant will recognize compensation taxable as ordinary income (and
subject to income tax withholding) upon exercise of a non-qualified stock option
equal to the excess of the fair market value of the shares purchased over their
exercise price, and the Company will be entitled to a corresponding deduction,
except to the extent the deduction limits of reasonable compensation and Section
162(m) of the Code apply. In general, a participant will not recognize income
(except for purposes of the alternative minimum tax) upon exercise of an
incentive stock option. If the shares acquired by exercise of an incentive stock
option are held for the longer of two years from the date the stock option was
granted and one year from the date it was exercised, any gain or loss arising
from a subsequent disposition of such shares will be taxed as long-term capital
gain or loss, and the Company will not be entitled to any deduction. If,
however, such shares are disposed of within the above-described period, then in
the year of such disposition the participant will recognize compensation taxable
as ordinary income equal to the excess of the lesser of (i) the amount realized
upon such disposition and (ii) the fair market value of such shares on the date
of exercise over the exercise price, and the Company will be entitled to a
corresponding deduction.

A participant will not recognize taxable income at the time SARs are
granted and the Company will not be entitled to a tax deduction at such time.
Upon exercise, the participant will recognize compensation taxable as ordinary
income (and subject to income tax withholding) in an amount equal to the fair
market value of

any shares delivered and the amount of cash paid by the Company. This amount
will be deductible by the Company as compensation expense, except to the extent
the deduction limits of reasonable compensation and Section 162(m) of the Code
apply.

A participant will not recognize taxable income at the time restricted
stock is granted and the Company will not be entitled to a tax deduction at such
time, unless the participant makes an election, pursuant to Section 83(b) of the
Code, to be taxed at such time. If such election is not made within 30 days of
the transfer of the stock, the participant will recognize compensation taxable
as ordinary income (and subject to income tax withholding) at the time the
restrictions lapse in an amount equal to the excess of the fair market value of
the shares at such time over the amount, if any, paid for such shares. The
amount of ordinary income recognized by making the above-described election or
upon the lapse of restrictions will be deductible by the Company as compensation
expense, except to the extent the deduction limits of reasonable compensation
and Section 162(m) of the Code apply. In addition, a participant receiving
dividends with respect to restricted stock for which the above-described
election has not been made and prior to the time the restrictions lapse will
recognize compensation taxable as ordinary income (and subject to income tax
withholding), rather than dividend income, in an amount equal to the dividends
paid and provided the Company reports these amounts on a properly filed Form W-2
or 1099, as applicable, the Company will be entitled to a corresponding
deduction, except to the extent the deduction limits of reasonable compensation
and Section 162(m) of the Code apply.

A participant will recognize compensation taxable as ordinary income (and
subject to income tax withholding) at the time bonus stock (i.e., stock not
subject to restriction) is granted in an amount equal to the then fair market
value of such stock. This amount will be deductible by the Company as
compensation expense, except to the extent the deduction limits of reasonable
compensation and Section 162(m) of the Code apply.

A participant will not recognize taxable income at the time performance
restricted units (i.e., stock awards which are subject to performance criteria)
are granted, and the Company will not be entitled to a tax deduction at such
time. Upon the settlement of such units, the participant will recognize
compensation taxable as ordinary income (and subject to income tax withholding)
in an amount equal to the fair market value of any shares delivered and the
amount of cash paid by the Company. This amount will be deductible by the
Company as compensation expense, except to the extent the deduction limits of
reasonable compensation and Section 162(m) of the Code apply.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR APPROVAL OF THE
PROPOSED AMENDMENTS TO THE HEALTH MANAGEMENT SYSTEMS, INC. 1999 LONG-TERM
INCENTIVE STOCK PLAN.

4. RATIFICATION OF THE SELECTION OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

The Board of Directors, in accordance with the recommendation of the Audit
and Compliance Committee, has selected, subject to ratification by shareholders,
KPMG LLP, independent certified public accountants, to audit the consolidated
financial statements of the Company and its subsidiaries for fiscal year 2002.
KPMG LLP has audited the Company's financial statements since fiscal year 1981.

AUDIT FEES

The aggregate fees billed and expected to be billed by KPMG LLP for the
audit of the Company's annual financial statements for fiscal year 2001, the
audit of the two month transition period of November 1, 2000 to December 31,
2000, the reviews of the financial statements included in the Company's
quarterly reports on Form 10-Q for fiscal year 2001, the review of the financial
statements for the transition period included in the Company's report on Form
10-Q, were $199,700. The final amount of such fees is still subject to review by
KPMG LLP and review and approval by the Company and the Audit and Compliance
Committee.

ALL OTHER FEES

The aggregate Other Fees billed by KPMG LLP for work performed in fiscal
year 2001 for audits of the Company's employee benefit plans, work on various
SEC filings and accounting advice with respect to discontinued operations,
change in year-end and disposal of businesses, were approximately $83,500. There
were no fees, no fees billed by KPMG LLP for financial information systems
design and implementation during 2001. The Audit and Compliance Committee
considered whether the provision of such other services was compatible with
maintaining KPMG LLP's independence.

The Company expects representatives of KPMG LLP to attend the Meeting, to
be available to respond to appropriate questions from shareholders, and to have
the opportunity to make a statement if so desired.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE PROPOSAL TO RATIFY THE
SELECTION OF KPMG LLP AS INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS FOR FISCAL
YEAR 2002.

ADDITIONAL INFORMATION

STOCK OWNERSHIP

The following table sets forth certain information regarding the beneficial
ownership of Common Stock as of March 31, 2002 by (a) each person known by the
Company to be the beneficial owner of more than 5% of the outstanding shares of
Common Stock, (b) each executive officer identified in the Summary Compensation
Table below, (c) each director and nominee for director, and (d) all executive
officers and directors as a group. Except as otherwise noted, the named
shareholder had sole voting and investment power with respect to such
securities.

<Table>
<Caption>
NAME AMOUNT PERCENTAGE
- ---- --------- ----------

Dimensional Fund Advisors Inc.
1229 Ocean Avenue, 11th Floor,
Santa Monica, CA 90401.................................... 1,270,175 7.0%
William F. Miller III(a).................................... 756,250 4.6%
Alan J. Hayes(b)............................................ 124,000 *
Robert M. Holster(c)........................................ 174,996 *
William C. Lucia(d)......................................... 54,212 *
Robert V. Nagelhout(e)...................................... 104,436 *
Philip Rydzewski(f)......................................... 50,001 *
Randolph G. Brown(g)........................................ 115,250 *
James T. Kelly(h)........................................... -- *
William W. Neal(i).......................................... 90,212 *
Galen D. Powers(j).......................................... 62,727 *
Ellen A. Rudnick(k)......................................... 52,042 *
Richard H. Stowe(l)......................................... 176,812 *
All executive officers and directors as a group (12
persons)(m)............................................... 1,760,938 9.2%
</Table>

- ---------------
* denotes percentage of ownership is less than 1%

(a) Includes outstanding options to purchase 206,250 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(b) Includes outstanding options to purchase 124,000 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(c) Mr. Holster became the Company's President and Chief Operating Officer on
March 30, 2001. Includes outstanding options to purchase 125,000 shares of
Common Stock that are currently exercisable or will become exercisable
before May 31, 2002. Also includes 19,996 shares of Common Stock owned by
members of the family of Mr. Holster, as to which Mr. Holster disclaims
beneficial ownership.

(d) Includes outstanding options to purchase 52,167 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(e) Includes 6,000 shares of Common Stock held in trusts for the benefit of
family members, as to which Mr. Nagelhout disclaims beneficial ownership.
Mr. Nagelhout resigned as an officer and Director of the Company in
December, 2001.

(f) Includes outstanding options to purchase 50,001 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(g) Includes outstanding options to purchase 115,250 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(h) Mr. Kelly became a Director in December 2001.

(i) Includes 32,980 shares of Common Stock owned by members of the family of
Mr. Neal, as to which Mr. Neal disclaims beneficial ownership. Also
includes outstanding options to purchase 52,792 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(j) Includes 237 shares of Common Stock owned by members of the family of Mr.
Powers, as to which Mr. Powers disclaims beneficial ownership. Also
includes outstanding options to purchase 62,490 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(k) Includes outstanding options to purchase 49,042 shares of Common Stock that
are currently exercisable or will become exercisable before May 31, 2002.

(l) Includes 9,000 shares of Common Stock owned by members of the family of Mr.
Stowe, as to which Mr. Stowe disclaims beneficial ownership. Also includes
outstanding options to purchase 120,500 shares of Common Stock that are
currently exercisable or will become exercisable before May 31, 2002.

(m) Includes outstanding options to purchase 1,044,992 shares of Common Stock
that are currently exercisable or will become exercisable before May 31,
2002.

EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE

The following table sets forth the cash and non-cash compensation for the
year ended December 31, 2001 and the two months ended December 31, 2000, the
transition period, and fiscal years ended October 31, 2000 and 1999 awarded to
or earned by the Chief Executive Officer and by each of the other six current
and former most highly compensated executive officers of the Company.

<Table>
<Caption>
LONG-TERM COMPENSATION
----------------------
ANNUAL COMPENSATION STOCK
FISCAL ----------------------------- RESTRICTED OPTIONS
NAME AND PRINCIPAL POSITION YEAR SALARY BONUS OTHER(a) STOCK AWARDED
- --------------------------- ---------- -------- ------- -------- ---------- -------

William F. Miller III(b)...... 2001 $400,000 $ -- $ 5,100 $574,000(b) 825,000
Chairman and Transition 66,667 -- -- -- --
Chief Executive Officer 2000 33,333 -- -- -- --
1999 -- -- -- -- --
Robert M. Holster(c).......... 2001 243,750 100,000 4,828 -- 775,000
President and Transition -- -- -- -- --
Chief Operating Officer 2000 -- -- -- -- --
1999 -- -- -- -- --
Alan Hayes(d)................. 2001 220,833 -- 3,375 -- 160,000
Chief Technology Officer, Transition 33,333 -- -- -- 65,000
Payor Services 2000 133,333 50,000 -- -- 50,000
1999 -- -- -- -- --
William Lucia................. 2001 206,000 135,000 2,725 -- 185,000
President, Payor Services Transition 28,333 -- -- -- --
Division 2000 150,000 -- 3,025 -- --
1999 132,667 14,000 3,000 -- --
Philip Rydzewski(e)........... 2001 91,077 40,000 1,200 -- 150,000
Senior Vice President and Transition -- -- -- -- --
Chief Financial Officer 2000 -- -- -- -- --
1999 -- -- -- -- --
Robert V. Nagelhout(f)........ 2001 312,000 156,000 5,100 -- --
Former President, Transition 52,000 -- -- -- --
Software Division 2000 312,000 -- 13,678 -- 10,000
1999 312,000 -- 11,338 -- 80,000
</Table>

- ---------------
(a) Includes matching contributions under the Company's 401(k) Plan.

(b) Mr. Miller joined the Company as Chief Executive Officer and a director as
of October 2, 2000. The restricted stock component of Mr. Miller's long-term
compensation consists of the application of the bonus otherwise payable to
Mr. Miller to pay the first principal installment and accrued interest on
his indebtedness to the Company (and to reimburse him for the related
payroll tax consequences), arising from the purchase of shares of the
Company's Common Stock in January 2001. See "Employment Agreements".

(d) Mr. Hayes joined the Company during 2000 as Chief Information Officer and
was subsequently re-assigned to Chief Technology Officer of the Payor
Services Division.

(e) Mr. Rydzewski joined the Company during 2001.

(f) Mr. Nagelhout resigned as an officer and Director of the Company in December
2001 upon the sale of Health Care microsystems, Inc.

EMPLOYMENT AGREEMENTS

William F. Miller III -- Chief Executive Officer

On October 2, 2000, Mr. Miller entered into an employment agreement (the
"Agreement") with the Company. The Agreement provides for his employment through
October 2, 2003 (the "Employment Term") (subject to earlier termination in
certain circumstances as described below), at a base salary of $400,000 per
year. Mr. Miller is eligible to receive bonus compensation from the Company in
respect of each fiscal year (or portion thereof) during the Employment Term, in
each case as may be determined by the Board of Directors of the Company in its
sole discretion on the basis of performance-based or such other criteria as may
be established from time to time by the Board of Directors of the Company. Mr.
Miller shall receive a minimum bonus from the Company in respect of each of the
first two fiscal years (or portion thereof) occurring during the Employment Term
(pro rated for any portion of a fiscal year occurring during the Employment
Term), of $80,000 and $40,000 for the fiscal years ending October 31, 2001 and
2002, respectively, payable on the December 15 following the end of such fiscal
year.

On January 10, 2001, as a condition of Mr. Miller's employment, the
Company's Accelerated Claims Processing, Inc. subsidiary, a Delaware
corporation, provided the financing for Mr. Miller to purchase directly from the
Company 550,000 shares of Common Stock. The loan, in the principal amount of
$721,785, bears interest at the rate of 6.5% per annum, and is payable annually
in two equal installments commencing January 2002. The loan is a full recourse
loan and is secured by the purchased shares and the shares issuable upon the
exercise of stock options. The bonus otherwise payable to Mr. Miller was applied
to pay the first installment of principal and interest on Mr. Miller's note to
the Company in January 2002.

Also in connection with his employment, on January 10, 2001, the
Compensation Committee granted Mr. Miller 750,000 options to purchase shares of
Common Stock at an exercise price of $1.31 per share (the then current market
price), with 100,000 shares vesting on the first anniversary of the grant, and
the remaining 650,000 shares vesting thereafter in eight equal quarterly
installments. These options were not granted pursuant to the Company's 1999
Long-Term Incentive Stock Plan and, therefore, the shares of Common Stock
issuable upon the exercise of these options are "restricted securities" within
the meaning of the federal securities laws.

If the Company terminates Mr. Miller's employment without "cause" or if his
employment ceases within 45 days of a change in control of the Company (both as
defined in the Agreement), Mr. Miller will be entitled to a continuation of
salary and group medical insurance for 24 months following termination of
employment. In addition, certain of his unvested options accelerate and certain
restrictions on his Common Stock are eliminated in the case of a change in
control, as defined in the agreement.

Robert M. Holster -- President and Chief Operating Officer

On March 30, 2001, Mr. Holster entered into an employment agreement (the
"Holster Agreement") with the Company. The Holster Agreement provides for his
employment through October 30, 2004 (the "Holster Employment Term") (subject to
earlier termination in certain circumstances as described below), at a base
salary of $325,000 per year. Mr. Holster is eligible to receive bonus
compensation from the Company in
17

respect of each fiscal year (or portion thereof) during the Holster Employment
Term, in each case as may be determined by the Board of Directors of the Company
in its sole discretion on the basis of performance-based or such other criteria
as may be established from time to time by the Board of Directors of the
Company. Additionally, the Holster Agreement provided a specific bonus of
$50,000 upon the successful divestiture of the Company's Health Care
microsystems, Inc. subsidiary.

Also in connection with his employment, on March 30, 2001, the Compensation
Committee granted Mr. Holster 700,000 options to purchase shares of Common Stock
at an exercise price of $1.19 per share (the then current market price), with
100,000 shares vesting on the first anniversary of the grant, and the remaining
600,000 shares vesting thereafter in eight equal quarterly installments. These
options were not granted pursuant to the Company's 1999 Long-Term Incentive
Stock Plan and, therefore, the shares of Common Stock issuable upon the exercise
of these options are "restricted securities" within the meaning of the federal
securities laws.

If the Company terminates Mr. Holster's employment without "cause" or if
his employment ceases within 45 days of a change in control of the Company (both
as defined in the Agreement), Mr. Holster will be entitled to a continuation of
salary and group medical insurance for 24 months following termination of
employment. In addition, certain of his unvested options accelerate in the case
of a change in control, as defined in the agreement.

William Lucia -- President, Payor Systems Division

In February 2001, in connection with the Company's strategic planning and
divestiture initiatives, the Company entered into an agreement entitling Mr.
Lucia, then General Manager of the Payor Services Division, to a guaranteed
bonus of $85,000 for fiscal year 2001, payable in January 2002, subject to
earlier payment under certain circumstances. In addition, if the Company had
terminated Mr. Lucia's employment without cause or if his employment ceased
under certain circumstances due to a change in control, Mr. Lucia would also
have been entitled to a continuation of salary for six months following
termination of employment. If the Company terminated Mr. Lucia's employment due
to a change in control requiring his relocation to offices more than 50 miles
from his current location, Mr. Lucia would have been entitled to a continuation
of salary for three months following termination of employment. In April 2001
pursuant to certain early entitlement provisions in the agreement, the
guaranteed bonus was accelerated and paid to Mr. Lucia.

Alan Hayes -- Chief Technology Officer, Payor Services Division

On March 1, 2001, Mr. Hayes entered into an employment agreement (the
"Hayes Agreement") with the Company in his then capacity as Chief Information
Officer. The Hayes Agreement provides for his employment through March 1, 2003
(the "Hayes Employment Term") (subject to earlier termination in certain
circumstances as described below), at a base salary of $225,000 per year. Mr.
Hayes is eligible to receive bonus compensation from the Company in respect of
each fiscal year (or portion thereof) during the Hayes Employment Term, in each
case as may be determined by the Board of Directors of the Company in its sole
discretion on the basis of performance-based or such other criteria as may be
established from time to time by the Board of Directors of the Company.

Also in connection with the Hayes Agreement, on April 9, 2001, the
Compensation Committee granted Mr. Hayes 85,000 options to purchase shares of
Common Stock at an exercise price of $1.27 per share (the then current market
price), with 17,000 shares vesting immediately, 17,000 shares vesting on
December 31, 2001, 25,500 vesting on December 31, 2002, and the remaining 25,500
shares vesting on December 31, 2003. The Hayes Agreement also provided for an
additional option grant of 75,000 shares on November 1, 2001 vesting as follows:
20% on the grant date and 40% on each successive annual anniversary of the
grant.

If the Company terminates Mr. Hayes's employment without "cause" or if his
employment ceases within 45 days of a change in control of the Company (both as
defined in the Agreement), Mr. Hayes will be entitled to a continuation of
salary and group medical insurance for 12 months following termination of
employment. In addition, certain of his unvested options accelerate in the case
of a change in control, as defined in the agreement.

STOCK OPTIONS

The Company's 1999 Long-Term Incentive Stock Plan allows grants of stock
options and other rights relating to its Common Stock. In general, whether
exercising stock options is profitable depends on the relationship between the
Common Stock's market price and the option's exercise price, as well as on the
optionee's investment decisions. Options that are "in the money" on a given date
can become "out of the money" if prices change on the stock market. For these
reasons, the Company believes that placing a current value on outstanding
options is highly speculative and may not represent the true benefit, if any,
that may be realized by the optionee. The following two tables give more
information on stock options.

The following table sets forth selected option grant information for the
year ended December 31, 2001 and the transition period from November 1, 2000 to
December 31, 2000 with respect to options awarded to the Chief Executive Officer
and each of the other six current and former most highly compensated executive
officers of the Company.

OPTIONS GRANTED IN THE LAST YEAR AND TRANSITION PERIOD

<Table>
<Caption>
POTENTIAL REALIZABLE VALUE
AT ASSUMED ANNUAL RATES
NUMBER % OF TOTAL OF STOCK PRICE APPRECIATION
TYPE OF OF OPTIONS EXERCISE FOR OPTION TERM(b)
OPTION OPTIONS GRANTED TO PRICE PER EXPIRATION ---------------------------
NAME GRANTED GRANTED EMPLOYEES(a) SHARE DATE 5% 10%
- ---- ------- ------- ------------ --------- ---------- ---------- ------------

YEAR ENDED DECEMBER 31, 2001
William F. Miller
III................. NQ 75,000 2.4% $2.48 12/12/11 $116,974 $ 296,436
NQ 750,000 24.4% 1.31 1/10/11 617,889 1,565,852
------- ---- ----- -------- -------- ----------
825,000 26.8% 734,863 1,862,288
------- ---- ----- -------- -------- ----------
Robert M Holster...... ISO 75,000 2.4% 2.48 12/12/11 116,974 296,436
NQ 700,000 22.8% 1.19 3/30/11 523,869 1,327,587
------- ---- ----- -------- -------- ----------
775,000 25.2% 640,844 1,624,024
------- ---- ----- -------- -------- ----------
Alan Hayes............ ISO 75,000 2.4% 1.73 11/1/11 81,599 206,788
ISO 85,000 2.8% 1.27 4/9/11 67,889 172,044
------- ---- ----- -------- -------- ----------
160,000 5.2% 149,488 378,833
------- ---- ----- -------- -------- ----------
William Lucia......... ISO 35,000 1.1% 2.48 12/12/11 54,588 138,337
ISO 150,000 4.9% 1.74 7/31/11 164,141 415,967
------- ---- ----- -------- -------- ----------
185,000 6.0% 218,730 554,304
------- ---- ----- -------- -------- ----------
Philip Rydzewski...... ISO 100,000 3.3% 2.48 12/12/11 155,966 395,248
ISO 50,000 1.6% 1.27 4/9/11 39,935 101,203
------- ---- ----- -------- -------- ----------
150,000 4.9% 195,901 496,451
------- ---- ----- -------- -------- ----------
Robert V. Nagelhout... -- -- -- -- -- -- --
</Table>

TWO MONTHS ENDED DECEMBER 31, 2000
William F. Miller
III................. -- -- -- $ -- -- $ -- $ --
Robert M Holster...... -- -- -- -- -- -- --
Alan Hayes............ ISO 65,000 11.3% 1.07 12/15/10 43,740 110,845
William Lucia......... -- -- -- -- -- -- --
Philip Rydzewski...... -- -- -- -- -- -- --
Robert V. Nagelhout... -- -- -- -- -- -- --
</Table>

- ---------------
(a) Represents individual option grant as a percentage of total options issued
in the year ended December 31, 2001 and the transition period from November
1, 2000 to December 31, 2000.

(b) The hypothetical potential appreciation shown in these columns reflects the
required calculations at compounded annual rates of 5% and 10% set by the
Securities and Exchange Commission, and therefore is not intended to
represent either historical appreciation or anticipated future price
appreciation of the Common Stock.

The following table sets forth selected stock option exercise information
for the year ended December 31, 2001 and the transition period from November 1,
2000 to December 31, 2000 and the number and value of stock options as of
December 31, 2001 and 2000 relating to the Chief Executive Officer and each of
the other six current and former most highly compensated executive officers of
the Company.

STOCK OPTIONS EXERCISED IN THE LAST YEAR AND TRANSITION PERIOD AND RELATED
PERIOD-ENDED
STOCK OPTION VALUES

<Table>
<Caption>
NUMBER OF UNEXERCISED VALUE OF UNEXERCISED
SHARES OPTIONS AT PERIOD-END OPTIONS AT PERIOD-END(a)
ACQUIRED ON VALUE ---------------------------- ----------------------------
NAME EXERCISE REALIZED EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
- ---- ----------- -------- ----------- ------------- ----------- -------------

YEAR ENDED DECEMBER 31, 2001
William F. Miller III...... -- $ -- 25,000 800,000 $ 18,000 $1,453,600
Robert M Holster........... -- -- 25,000 750,000 18,000 1,443,000
Alan Hayes................. -- -- 124,000 151,000 226,120 186,630
William Lucia.............. -- -- 52,167 170,333 52,200 192,000
Philip Rydzewski........... -- -- 33,334 116,666 24,000 144,500
Robert V. Nagelhout........ -- -- 110,600 -- -- --
</Table>

TWO MONTHS ENDED DECEMBER 31, 2000
William F. Miller III...... -- $ -- -- -- $ -- $ --
Robert M Holster........... -- -- -- -- -- --
Alan Hayes................. -- -- 10,000 105,000 -- 138,450
William Lucia.............. -- -- 10,500 27,000 -- --
Philip Rydzewski........... -- -- -- -- -- --
Robert V. Nagelhout........ -- -- 110,500 78,500 -- --
</Table>

- ---------------
(a) Value of unexercised "in-the-money" options is determined by multiplying the
number of shares subject to such options by the difference between the
exercise price per share and $3.20 and $1.34, the average of the high and
low price per share of the Common Stock on the Nasdaq-Amex National Market
System on December 31, 2001 and 2000, respectively.

401(K) PLAN

Effective November 1, 1997, the Company established a 401(k) Plan to
replace its terminated profit sharing plan. The 401(k) Plan permits an employee
to contribute a portion of the employee's compensation, subject to certain
limitations. At its discretion, the Company may make annual contributions to the
401(k) Plan for the benefit of participating employees. For the fiscal year
ended December 31, 2001, the two month transition period ended December 31,
2000, and the fiscal years ended October 31, 2000 and 1999, 401(k) Plan expense
was $264,000, $95,000, $653,000 and $506,000, respectively.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

The Compensation Committee is comprised of Richard H. Stowe and William W.
Neal, each of whom is a non-employee director of the Company. No member of this
Committee was at any time during fiscal year 2001 or at any other time an
officer or employee of the Company. No executive officer of the Company served
on the Compensation Committee of another entity or on any other committee of the
Board of directors of another entity performing similar functions during the
Company's last fiscal year.

Notwithstanding contrary statements set forth in any of the Company's
previous filings under the Securities Act of 1933 (the "Securities Act") or the
Exchange Act that might incorporate future filings, including this Proxy
Statement, the Compensation Committee report, the Audit and Compliance Committee
Report and the performance graph set forth below shall not be incorporated by
reference into such future filings.

COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION

This report provides an explanation of the philosophy underlying the
Company's executive compensation program and details on how decisions were
implemented during fiscal year 2001 regarding the compensation paid to the
Company's executive officers.

The Company's mission is to be a significant provider of quality services
in the markets it serves. To support this and other strategic objectives as
approved by the Board of Directors and to provide adequate returns to
shareholders, the Company must compete for, attract, develop, motivate, and
retain top quality

executive talent at the corporate office and operating business units of the
Company during periods of both favorable and unfavorable business conditions.

The Company's executive compensation program is a critical management tool
in achieving this goal. "Pay for performance" is the underlying philosophy for
the Company's executive compensation program. Consistent with this philosophy,
the program has been carefully conceived and is independently administered by
the Compensation Committee (the "Committee") of the Board of Directors, which is
comprised entirely of non-employee directors. The program is designed to link
executive pay to corporate performance, including share price, recognizing that
there is not always a direct correlation in the short-term between executive
performance and share price.

The program is designed and administered to:

- reward individual and team achievements that contribute to the attainment
of the Company's business goals; and

- provide a balance of total compensation opportunities, including salary,
bonus, and longer-term cash and equity incentives, that are competitive
with similarly situated companies and reflective of the Company's
performance.

In seeking to link executive pay to corporate performance, the Committee
believes that the most appropriate measure of corporate performance is the
increase in long-term shareholder value, which involves improving such
quantitative performance measures as revenue, net income, cash flow, operating
margins, earnings per share, and return on shareholders' equity. The Committee
may also consider qualitative corporate and individual factors which it believes
bear on increasing the long-term value of the Company to its shareholders. These
include: (i) the development of competitive advantages; (ii) the ability to deal
effectively with the growing complexity of the Company's businesses; (iii)
success in developing business strategies, managing costs, and improving the
quality of the Company's services as well as customer satisfaction; (iv)
execution of divestitures, acquisitions, and strategic partnerships, (v)
implementation of operating efficiencies, and (vi) the general performance of
individual job responsibilities.

The Company's executive compensation program consists of: (i) a base
salary; (ii) an annual bonus; and (iii) a long-term incentive represented by
stock options.

COMPENSATION OF EXECUTIVE OFFICERS

Salary. In determining the amount of compensation to be paid to the
executive officers of the Company, the Committee adheres to long established
compensation policies of the Company pursuant to which executive compensation is
determined. Base salary determinants include the prevailing rate of compensation
for positions of like responsibility in the particular geographic area, the
level of the executive's compensation in relation to other executives of the
Company with the same, more, or less responsibilities, and the tenure of the
individual. To ensure both competitiveness and appropriateness of base salaries,
the Company retains professional consultants on a periodic basis to update the
job classification and pay scale structure pursuant to which individual
executives (and the remainder of the Company's employees) are classified and the
pay ranges with which their jobs are associated.

Bonus. Bonuses are intended to reward both overall corporate performance
and an individual's participation in attaining such performance. From time to
time, bonuses are also awarded to augment base salary when a determination has
been made that an executive's salary is not competitive in light of the factors
discussed above.
22

Stock Options. The longer-term component of the Company's executive
compensation program consists of stock options. The options generally permit the
option holder to buy the number of shares of the underlying Common Stock (an
"option exercise") at a price equal to or greater than the market price of the
stock at the time of grant. Thus, the options generally gain value only to the
extent the stock price exceeds the option exercise price during the life of the
option. Generally a portion of the options vest over a period of several years
and expire no later than ten years after grant. Stock options are granted upon
the recommendation of management and approval of the Committee based upon their
subjective evaluation of the appropriate amount for the level and amount of
responsibility of each executive officer.

COMPENSATION OF THE CHIEF EXECUTIVE OFFICER

Determination of the Company's compensation of William F. Miller III, the
Company's Chief Executive Officer, takes into account the factors described
above as pertinent to the remainder of the Company's executives and employees,
while also taking into consideration the proprietary nature of the Company's
business and efforts expended in connection with development of the Company's
business strategy and product development activities. The Committee more
specifically took into account (i) Mr. Miller's success in completing the
Company's strategic review which included the sales of three business units and
the formal closing of another, (ii) Mr. Miller's success in the development of a
new executive team and strengthening the operating division management teams,
and (iii) the amount of Mr. Miller's compensation relative to chief executive
officers of comparable companies.

OTHER

Section 162(m) of the Internal Revenue Code prohibits the Company from
deducting any compensation in excess of $1,000,000 paid to certain of its
executive officers, except to the extent that such compensation is paid pursuant
to a shareholder approved plan upon the attainment of specified performance
objectives. The Committee believes that tax deductibility is an important
factor, but not the sole factor, to be considered in setting executive
compensation policy. Accordingly, the Committee generally intends to take such
reasonable steps as are required to avoid the loss of a tax deduction due to
Section 162(m), but reserves the right, in appropriate circumstances, to pay
amounts which are not deductible.

COMPENSATION COMMITTEE

Richard H. Stowe
William W. Neal

REPORT OF AUDIT AND COMPLIANCE COMMITTEE

In accordance with a written charter, adopted by the Audit and Compliance
Committee (the "Committee") of the Board of Directors (the "Board"), the
Committee, among its other duties, assists the Board in fulfilling its
responsibility for oversight of the quality and integrity of the accounting,
auditing, and financial reporting practices of the Company. During fiscal year
2001, the Committee met four times. The Committee discussed the interim
financial information contained in each quarterly earnings announcement with the
Company's Chief Financial Officer and independent auditors prior to public
release. The Committee also reviewed management's proposal to change the
Company's fiscal year end from October 31 to December 31, and recommended
approval of the change to the Board.

In discharging its oversight responsibility as to the audit process, the
Committee obtained from the independent auditors a formal written statement
describing all relationships between the auditors and the Company that might
bear on the auditors' independence consistent with Independence Standards Board
Standard No. 1, "Independence Discussions with Audit Committees," discussed with
the auditors any relationships that may impact their objectivity and
independence and satisfied itself as to the auditors' independence. The
Committee also discussed with senior management, including the Chief Financial
Officer of the Company, and the independent auditors the quality and adequacy of
the Company's internal controls and organization, responsibilities, and budget.
The Committee reviewed with both the independent auditors and the Company's
Chief Financial Officer their audit plans, audit scope and identification of
audit risks.

The Committee discussed and reviewed with the independent auditors all
communications required by generally accepted auditing standards, including
those described in Statement on Auditing Standards No. 61, as amended,
"Communications with Audit Committees" and, with and without management present,
discussed and reviewed the results of the independent auditors' examination of
the financial statements.

The Committee reviewed the audited financial statements of the Company as
of and for the two month transition period ended December 31, 2000 and the
fiscal year ended December 31, 2001 with management and the independent
auditors. Management has the responsibility for the preparation of the Company's
financial statements and the independent auditors have the responsibility for
the examination of those statements.

Based on the above mentioned review and discussions with management and the
independent auditors, the Committee recommended to the Board that the Company's
audited financial statements be included in its Annual Report on Form 10-K for
the fiscal year ended December 31, 2001, for filing with the Securities and
Exchange Commission. The Committee also recommended the reappointment, subject
to shareholder approval, of the independent auditors and the Board concurred in
such recommendation.

AUDIT AND COMPLIANCE COMMITTEE

Galen D. Powers
Randolph G. Brown
Richard H. Stowe

SHAREHOLDER RETURN PERFORMANCE GRAPHS

The graph presented below provides a comparison between the cumulative
total shareholder return (assuming the reinvestment of dividends) on the Common
Stock since the Company's initial public offering on December 17, 1992 and the
Nasdaq U.S. companies index, the Nasdaq computer and data processing service
companies index, and the Nasdaq health service companies index, over the same
period. The graph assumes the investment of $100 in the Common Stock and each of
the indices.
[PERFORMANCE GRAPH]

<Table>
<Caption>
NASDAQ COMPUTER &
DATA PROCESSING NASDAQ HEALTH
HMSY NASDAQ US COMPOSITE SERVICES STOCKS SERVICES STOCKS
---- ------------------- ----------------- ---------------

Dec-92 100.00 100.00 100.00 100.00
Oct-93 142.00 118.00 110.00 102.00
Oct-94 189.00 119.00 132.00 130.00
Oct-95 320.00 160.00 201.00 133.00
Oct-96 353.00 189.00 233.00 152.00
Oct-97 98.00 249.00 315.00 166.00
Oct-98 103.00 278.00 405.00 129.00
Oct-99 65.00 470.00 761.00 93.00
Oct-00 23.00 530.00 813.00 131.00
Dec-00 23.00 387.00 548.00 150.00
Dec-01 47.00 307.00 441.00 162.00
</Table>

CERTAIN TRANSACTIONS

Robert V. Nagelhout -- former President, Software Systems and Services Division

In December 2001, the Company sold its wholly owned subsidiary, Health Care
microsystems, Inc. ("HCm"), to HCm's executive management team, led by Mr.
Nagelhout. The sale price of $9.8 million consisted of $9.2 million in cash at
closing and the assumption of $600,000 of the Company's liabilities.

The sale price was determined by arms length negotiation between management
of the Company and the purchasers, within parameters established by the Board of
Directors of the Company, excluding Mr. Nagelhout. Additionally, the Company
obtained a fairness opinion regarding the sale price, prepared by an independent
investment banking firm. Mr. Nagelhout subsequently resigned from the Company's
Board of Directors later in December 2001.

In February 2001, in connection with the Company's strategic planning and
divestiture initiatives, the Company entered into an agreement entitling Mr.
Nagelhout to a guaranteed bonus of $156,000 for fiscal year 2001, payable in
January 2002, subject to earlier payment under certain circumstances. In
addition, if the Company terminated Mr. Nagelhout's employment without cause or
if his employment ceased under certain circumstances due to a change in control,
Mr. Nagelhout would also have been entitled to a continuation of salary for six
months following termination of employment. If the Company terminated Mr.
Nagelhout's employment due to a change in control requiring his relocation to
offices more than 50 miles from his current location, Mr. Nagelhout would have
been entitled to a continuation of salary for three months following termination
of employment. In December 2001 upon the sale of HCm, Mr. Nagelhout's guaranteed
bonus entitlement was accelerated.

Alan L. Bendes -- former Chief Financial Officer

On January 2, 1999, Mr. Bendes entered into an agreement with the Company
confirming his employment as a Senior Vice President and the Chief Financial
Officer of the Company effective February 1, 1999 at a base salary of $215,000
per year. In addition, Mr. Bendes was granted options under the Company's 1999
Long-Term Incentive Stock Plan to purchase 105,000 shares of Common Stock at an
exercise price of $4.70 per share (the then current market price), of which
21,000 options vested on the grant date, an additional 21,000 vested on January
31, 2000; and the remaining 63,000 options vest on January 31, 2003 subject to
partial acceleration upon realization of certain annual performance measures by
the Company. If the Company terminated Mr. Bendes' employment without cause, or
if his employment ceased due to either a change in control of the Company (both
as defined in the agreement) or a relocation of the Company's New York City
offices more than 25 miles from its current location, Mr. Bendes would be
entitled to a continuation of salary and group medical insurance for 12 months
following termination of employment, as well as acceleration of certain of his
unvested options. Consistent with the terms of this agreement, upon Mr. Bendes
separation from the Company in June 2001, the Company is continuing his base
compensation and group medical insurance for 12 months, and certain options
continue to vest according to their original vesting terms.

OTHER BUSINESS

As of the date of this Proxy Statement, the Board of Directors knows of no
business to be presented at the Meeting other than as set forth herein. If other
matters properly come before the Meeting, the persons named as proxies will vote
on such matters in their discretion.

SHAREHOLDER PROPOSALS FOR 2003 ANNUAL MEETING

Any shareholder proposals intended to be presented at the Company's 2003
Annual Meeting of Shareholders must be received by the Secretary, Health
Management Systems, Inc., 401 Park Avenue South, New York, New York 10016, no
later than December 30, 2002, in order to be considered for inclusion in the
Company's Proxy Statement and form of proxy relating to such Meeting. Moreover,
with regard to any proposal by a shareholder not seeking to have such proposal
included in the Proxy Statement but seeking to have such proposal considered at
the 2003 Annual Meeting, if such shareholder fails to notify the Company in the
manner set forth above of such proposal no later than March 14, 2003, then the
persons appointed as proxies may exercise their discretionary voting authority
if the proposal is considered at the 2003 Annual Meeting notwithstanding that
shareholders have not been advised of the proposal in the Proxy Statement for
the 2003 Annual Meeting. Any proposals submitted by shareholders must comply in
all respects with (i) the rules and regulations of the Securities and Exchange
Commission, (ii) the provisions of the Company's Certificate of Incorporation
and by-laws, and (iii) New York law.

ANNUAL REPORT

The Company's 2001 Annual Report on Form 10-K is concurrently being mailed
to shareholders. The Annual Report contains consolidated financial statements of
the Company and its subsidiaries and the report thereon of KPMG LLP, independent
certified public accountants.

BY ORDER OF THE BOARD OF DIRECTORS

/s/ KATHY L. ARENDT
Kathy L. Arendt
Secretary

Dated: April 30, 2002

IT IS IMPORTANT THAT PROXIES BE RETURNED PROMPTLY. THEREFORE, SHAREHOLDERS
ARE URGED TO COMPLETE, SIGN, DATE, AND RETURN THE ACCOMPANYING FORM OF PROXY IN
THE ENCLOSED ENVELOPE.

EXHIBIT A

HEALTH MANAGEMENT SYSTEMS, INC.

AMENDED 1999 LONG-TERM INCENTIVE STOCK PLAN

ARTICLE I -- PURPOSES

The purposes of the Health Management Systems, Inc. 1999 Long-Term
Incentive Stock Plan are to promote the interests of the Corporation and its
shareholders by strengthening the Corporation's ability to attract and retain
highly competent officers and other employees, and to provide a means to
encourage stock ownership and proprietary interest in the Corporation by such
persons. The 1999 Long-Term Incentive Stock Plan is intended to provide plan
participants with stock-based incentive compensation which is not subject to the
deduction limitation rules prescribed under Section 162(m) of the Internal
Revenue Code of 1986, as amended (the "Code"), and should be construed to the
extent possible as providing for remuneration which is "performance-based
compensation" within the meaning of Section 162(m) of the Code and the
regulations promulgated thereunder.

ARTICLE II -- DEFINITIONS

Unless the context clearly indicates otherwise, the following terms shall
have the following meanings:

a. "AWARD" means, individually or in the aggregate, an award granted
to a Participant under the Plan in the form of an Option, a Stock Award, or
an SAR, or any combination of the foregoing.

b. "BOARD" means the Board of Directors of Health Management Systems,
Inc.

c. "COMMITTEE" means the Compensation Committee of the Board of
Directors, a subcommittee thereof, or such other committee as may be
appointed by the Board of Directors. The Committee shall be comprised of
two or more members of the Board of Directors who shall be "non-employee
directors" under Rule 16b-3 of the Exchange Act and "outside directors"
under Section 162(m) of the Code.

d. "CORPORATION" means Health Management Systems, Inc., or any entity
that is directly or indirectly controlled by Health Management Systems,
Inc., and its subsidiaries.

e. "EXCHANGE ACT" means the Securities Exchange Act of 1934, as
amended.

f. "FAIR MARKET VALUE" means the fair market value of a Share as of
the relevant date of determination, as determined in accordance with a
valuation methodology approved by the Committee. In the absence of any
alternative valuation methodology approved by the Committee, the Fair
Market Value of a Share shall equal the average of the highest and the
lowest quoted selling price of a Share as reported on the composite tape
for the principal national securities exchange on which the Shares are
traded on that date, or, in the event that the Shares are not listed for
trading on a national securities exchange but are quoted on an automated
system, on such automated system, in any such case on the valuation date
(or, if there were no sales on the valuation date, the average of the
highest and the lowest quoted selling prices as reported on said composite
tape or automated system for the most recent day before the valuation date
during which a sale occurred).

g. "INCENTIVE STOCK OPTION" means a stock option that complies with
Section 422 of the Code, or any successor law.
E-1

h. "NON-QUALIFIED STOCK OPTION" means a stock option that does not
meet the requirements of Section 422 of the Code, or any successor law.

i. "OPTION" means an option awarded under Article VI to purchase
Shares. An Option may be either an Incentive Stock Option or a
Non-Qualified Stock Option, as determined by the Committee in its sole
discretion.

j. "PARTICIPANT" means, (i) with respect to an Incentive Stock Option,
any full-time employee of the Corporation, including an officer or director
of the Corporation and (ii) with respect to all other Awards which may be
granted under the Plan, any individual employed by, or performing services
for, the Corporation, including, without limitation, officers and directors
of the Corporation.

k. "PLAN" means this Health Management Systems, Inc. 1999 Long-Term
Incentive Stock Plan, as amended and restated from time to time.

l. "PRIOR PLAN" means the Health Management Systems, Inc. Stock Option
and Restricted Stock Purchase Plan, as amended and restated from time to
time.

m. "SAR" means a stock appreciation right.

n. "SHARES" means shares of the Corporation's common stock, $.01 par
value per share.

o. "STOCK AWARD" means an Award made under Article VI in Shares.

p. "SUBSTITUTE AWARD" has the meaning set forth in Article V(b).

The term "CHANGE OF CONTROL" has the meaning set forth in Article X.

ARTICLE III -- EFFECTIVE DATE AND DURATION

The Plan shall become effective upon its approval by the shareholders of
the Corporation. Prior to such shareholder approval, the Committee may grant
Awards conditioned on shareholder approval. If such shareholder approval is not
obtained at or before the first annual meeting of shareholders to occur after
the adoption of the Plan by the Board (including any adjournment or adjournments
thereof), the Plan and any Awards made thereunder shall terminate ab initio and
be of no further force and effect. In no event shall any Awards be made under
the Plan after January 10, 2009, which is the day before the tenth anniversary
of the date of the Plan's adoption by the Board.

ARTICLE IV -- ADMINISTRATION

The Committee shall be responsible for administering the Plan, and shall
have full power to interpret the Plan and to adopt such rules, regulations and
guidelines for carrying out the Plan as it may deem necessary or appropriate.
This power includes, but is not limited to, selecting Award recipients,
establishing all Award terms and conditions, adopting procedures and regulations
governing Awards, and making all other determinations necessary or advisable for
the administration of the Plan. All decisions made by the Committee shall be
final and binding on all persons.

The Committee may delegate some or all of its power to the Chairman and
Chief Executive Officer or other executive officer of the Corporation as the
Committee deems appropriate; provided, that (i) the Committee may not delegate
its power with regard to the grant of an Award to any person who is a "covered
employee" within the meaning of Section 162(m) of the Code, or any successor
law, or who, in the Committee's judgment, is likely to be a covered employee at
any time during the period an Award to such
E-2

employee would be outstanding, and (ii) the Committee may not delegate its power
with regard to the selection for participation in the Plan of an officer or
other person subject to Section 16 of the Exchange Act or decisions concerning
the timing, pricing or amount of an Award to such an officer or other person.

ARTICLE V -- AVAILABLE SHARES

a. General. Subject to adjustment as provided in Article V(d) of the Plan,
the number of Shares that may be issued under the Plan shall not exceed, in the
aggregate, 6,251,356 shares, comprised of:

(i) 4,751,356 shares of Common Stock that were originally authorized
for issuance under the Prior Plan; plus

(ii) 1,500,000 newly authorized and unissued shares of Common Stock.

Shares issued under this Plan may be either authorized but unissued shares,
treasury shares or any combination thereof. No fractional Shares shall be
issued. Cash may be paid in lieu of any fractional Shares in settlement of
Awards.

b. Rules Applicable to Determining Shares Available for Issuance. For
purposes of determining the number of Shares that remain available for issuance,
the following shares shall be added back to the limit set forth in Article V(a)
above and again be available for Awards:

(i) The number of Shares tendered to pay the exercise price of an
Option or other Award;

(ii) The number of Shares withheld from any Award to satisfy a
Participant's tax withholding obligations or, if applicable, to pay the
exercise price of an Option or other Award;

(iii) The number of Shares subject to an Option or other outstanding
Award which are not issued by reason of the expiration, termination,
cancellation or forfeiture of such Award; and

(iv) Any Shares acquired pursuant to the exercise of an Option or
other Award which thereafter are repurchased by the Corporation.

In addition, the number of Shares subject to Awards that are granted in
substitution of an option or other award (a "Substitute Award") issued by an
entity acquired by (or whose assets are acquired by) the Corporation shall not
reduce the number of Shares available under the Plan.

c. Special Limits. The number of Shares for which Awards may be granted to
any person in any fiscal year shall not exceed 300,000.

d. Adjustments. In the event of any stock dividend, stock split,
combination or exchange of securities, merger, consolidation, recapitalization,
spin-off or other distribution (other than normal cash dividends) of any or all
of the assets of the Corporation to shareholders, or any other similar change or
event, such proportionate adjustments, if any, as the Committee in its
discretion may deem appropriate to reflect such change or event shall be made
with respect to the number and class of securities available under the Plan, the
number and class of securities subject to each outstanding Option and the
purchase price per security, the terms of each outstanding SAR, and the number
and class of securities subject to each outstanding Stock Award shall be
appropriately adjusted by the Committee, such adjustments to be made in the case
of outstanding Options without an increase in the aggregate purchase price. If
any such adjustment would result in a fractional security being (a) available
under the Plan, such fractional security shall be disregarded, or (b) subject to
an Award, the Corporation shall pay the holder of such Award, in connection with
the first vesting, exercise or settlement of such Award in whole or in part
occurring after such adjustment, an amount
E-3

in cash determined by multiplying (i) the fraction of such security (rounded to
the nearest hundredth) by (ii) the excess, if any, of (A) the Fair Market Value
on the vesting, exercise or settlement date over (B) the exercise price, if any,
of such Award.

ARTICLE VI -- AWARDS

a. General. The Committee shall determine the type or types of Award(s) to
be made to each Participant. Awards may be granted singly, in combination or in
tandem. In the sole discretion of the Committee, Awards also may be made in
combination or in tandem with, in replacement of, as alternatives to, or as the
payment form for grants or rights under any other compensation plan of the
Corporation including a plan of any entity acquired by (or whose assets are
acquired by) the Corporation. The Committee shall have full authority to
determine and specify in the applicable agreement reflecting an Award the
effect, if any, that a Participant's termination of employment for any reason
will have on the vesting, exercisability, payment or lapse of restrictions
applicable to an Award. With respect to the foregoing, the terms and conditions
of an Incentive Stock Option may (but need not) include any of the following
provisions:

(i) In the event the full-time employment of a Participant is
terminated by the Corporation or any parent or subsidiary (as those terms
are defined in Sections 424(e) and 424(f) of the Code, or any successor
law) of the Corporation for any reason other than "for cause," as
determined by the Board, the unexercised portion of any Incentive Stock
Option held by such Participant at that time may only be exercised within
three months after the date on which the Participant ceased to be so
employed, and only to the extent that the Participant could have otherwise
exercised such Incentive Stock Option as of the date on which he ceased to
be so employed.

(ii) In the event the full-time employment of a Participant is
terminated by the Corporation or any parent or subsidiary (as those terms
are defined in Sections 424(e) and 424(f) of the Code, or any successor
law) of the Corporation "for cause," as determined by the Board, or if such
employment is terminated voluntarily by the Participant, the unexercised
portion of any Incentive Stock Option held by such Participant shall
terminate immediately effective the date the Participant ceased to be so
employed.

(iii) In the event a Participant shall cease to be employed by the
Corporation or any parent or subsidiary (as those terms are defined in
Sections 424(e) and 424(f) of the Code, or any successor law) of the
Corporation on a full time basis by reason of his "disability" (within the
meaning of Section 422 of the Code or any successor law) or on account of
death or retirement, the unexercised portion of any Incentive Stock Option
held by such Participant at that time may only be exercised within one year
after the date on which the Participant ceased to be so employed (or for
such shorter exercise periods that may apply for purposes of Section 422 of
the Code, or any successor law), and only to the extent that the
Participant could have otherwise exercised such Incentive Stock Option as
of the date on which the Participant ceased to be so employed.

b. Types of Awards. The types of Awards that may be granted under the Plan
are:

(i) Options. An Option shall represent the right to purchase a
specified number of Shares during a specified period up to ten years as
determined by the Committee. The purchase price per Share for each Option
shall not be less than 100% (110% in the case of an Incentive Stock Option
granted to an optionee ("10% Stockholder") who, at the time of grant, owns
stock possessing more than 10% of the total combined voting power of all
classes of stock of the Corporation or its parent (as defined in Section
424(e) of the Code, or any successor law) or its subsidiaries) of the Fair
Market Value on the date of grant; provided, that a Substitute Award may be
granted with a purchase price per Share that is
E-4

intended to preserve the economic value of the award which the Substitute
Award replaced. The term of each Option shall be fixed by the Committee,
but no Incentive Stock Option shall be exercisable more than ten years
(five years, in the case of an Incentive Stock Option granted to a 10%
Stockholder) after the date on which the Option is granted. If an Option is
granted retroactively in substitution for an SAR, the Fair Market Value in
the Award agreement may be the Fair Market Value on the grant date of the
SAR. An Option may be in the form of an Incentive Stock Option or a
Non-Qualified Stock Option, as determined by the Committee. The Shares
covered by an Option may be purchased, in accordance with the applicable
Award agreement, by cash payment or such other method permitted by the
Committee, including (1) tendering Shares valued at the Fair Market Value
at the date of exercise; (2) authorizing a third party to sell the Shares
(or a sufficient portion thereof) acquired upon exercise of an Option, and
assigning the delivery to the Corporation of a sufficient amount of the
sale proceeds to pay for all the Shares acquired through such exercise and
any tax withholding obligations resulting from such exercise; or (3) any
combination of the above. In the case of an Incentive Stock Option, the
aggregate Fair Market Value of Shares (determined at the time of grant of
the Option) with respect to which Incentive Stock Options are exercisable
for the first time by an optionee during any calendar year (under all such
plans of optionee's employer corporation and its parent and subsidiaries
(as those terms are defined in Sections 424(e) and 424(f) of the Code, or
any successor law)) shall not exceed $100,000.

(ii) SARs. An SAR shall represent a right to receive a payment, in
cash, Shares or a combination, equal to the excess of the Fair Market Value
of a specified number of Shares on the date the SAR is exercised over the
Fair Market Value on the grant date of the SAR as set forth in the Award
agreement, except that if an SAR is granted retroactively in substitution
for an Option, the designated Fair Market Value in the Award agreement may
be the Fair Market Value on the grant date of the Option. An SAR may be
granted alone or in addition to other Awards, or in tandem with an Option.
An SAR granted in tandem with an Option may be granted either at the same
time as such Option or subsequent thereto. If granted in tandem with an
Option, an SAR shall cover the same number of Shares as covered by the
Option (or such lesser number of shares as the Committee may determine) and
shall be exercisable only at such time or times and to the extent the
related Option shall be exercisable, and shall have the same term and
exercise price as the related Option (which, in the case of an SAR granted
after the grant of the related Option, may be less than the Fair Market
Value per Share on the date of grant of the tandem SAR). Upon exercise of
an SAR granted in tandem with an Option, the related Option shall be
canceled automatically to the extent of the number of Shares covered by
such exercise; conversely, if the related Option is exercised as to some or
all of the Shares covered by the tandem grant, the tandem SAR shall be
canceled automatically to the extent of the number of Shares covered by the
Option exercise.

(iii) Stock Awards. A Stock Award shall represent an Award made in or
valued in whole or in part by reference to Shares, such as performance or
phantom shares or units. Stock Awards may be payable in whole or in part in
Shares. All or part of any Stock Award may be subject to conditions and
restrictions established by the Committee, and set forth in the Award
agreement or other plan or document, which may include, but are not limited
to, continuous service with the Corporation, and/or the achievement of one
or more performance goals. The performance criteria that may be used by the
Committee in granting Stock Awards contingent on performance goals shall
consist of total shareholder return, net sales, operating income, income
before income taxes, net income, net income per share (basic or diluted),
profitability as measured by return ratios, including return on invested
capital, return on equity and return on investment, cash flows, market
share or cost reduction goals. The Committee may select one criterion or
multiple criteria for measuring performance, and the measurement may be
based on Corporation or business unit performance, or based on comparative
performance with other companies.
E-5

ARTICLE VII -- DIVIDENDS AND DIVIDEND EQUIVALENTS

The Committee may provide that any Awards under the Plan earn dividends or
dividend equivalents. Such dividends or dividend equivalents may be paid
currently or may be credited to a Participant's Plan account. Any crediting of
dividends or dividend equivalents may be subject to such restrictions and
conditions as the Committee may establish, including reinvestment in additional
Shares or Share equivalents.

ARTICLE VIII -- PAYMENTS AND PAYMENT DEFERRALS

Payment of Awards may be in the form of cash, Shares, other Awards or
combinations thereof as the Committee shall determine, and with such
restrictions as it may impose. The Committee, either at the time of grant or by
subsequent amendment, may require or permit Participants to elect to defer the
issuance of Shares or the settlement of Awards in cash under such rules and
procedures as it may establish under the Plan. It also may provide that deferred
settlements include the payment or crediting of interest on the deferral
amounts, or the payment or crediting of dividend equivalents where the deferral
amounts are denominated in Share equivalents.

ARTICLE IX -- TRANSFERABILITY

a. Unless otherwise specified in an Award agreement, Awards shall not be
transferable or assignable other than by will or the laws of descent and
distribution or pursuant to beneficiary designation procedures approved by the
Company. The interests of Participants under the Plan are not subject to their
debts or other obligations and, except as may be required by the tax withholding
provisions of Code or any state's income tax act, or pursuant to an agreement
between a Participant and the Corporation, may not be voluntarily sold,
transferred, alienated, assigned or encumbered.

b. Notwithstanding the foregoing, the Committee, in its discretion and
subject to such limitations and conditions as the Committee deems appropriate,
may (i) amend Awards of Incentive Stock Options to convert the Options granted
thereby to Non-Qualified Stock Options, or (ii) grant Non-Qualified Stock
Options, in each case on terms which permit the Participant to transfer all or a
part of the Option, for estate or tax planning purposes or for donative
purposes, and without consideration, to a member of the Participant's immediate
family (as defined by the Committee), a trust for the exclusive benefit of such
immediate family members, or a partnership, corporation or limited liability
company the equity interests of which are owned exclusively by the Participant
and/or one or more members of the Participant's family.

ARTICLE X -- CHANGE OF CONTROL

Either in contemplation of or in the event of a Change of Control (as
defined below), the Committee may provide for appropriate adjustments (including
acceleration of vesting and settlements of or substitutions for Awards either at
the time an Award is granted or at a subsequent date).

A "Change of Control" shall occur when:

a. a "Person" (which term, when used in this Article X, shall have the
meaning it has when it is used in Section 13(d) of the Exchange Act, but
shall not include the Corporation, any trustee or other fiduciary holding
securities under an employee benefit plan of the Corporation, or any
corporation owned, directly or indirectly, by the shareholders of the
Corporation in substantially the same proportions as their ownership of
Voting Stock (as defined below) of the Corporation) is or becomes, without
the prior consent of a majority of the Continuing Directors of the
Corporation (as defined below), the Beneficial

E-6

Owner (as defined in Rule 13d-3 promulgated under the Exchange Act),
directly or indirectly, of Voting Stock (as defined below) representing
twenty percent or more of the combined voting power of the Corporation's
then outstanding securities; or

b. the shareholders of the Corporation approve a reorganization,
merger or consolidation or the Corporation sells, or otherwise disposes of,
all or substantially all of the Corporation's property and assets, or the
Corporation liquidates or dissolves (other than a reorganization, merger,
consolidation or sale which would result in all or substantially all of the
beneficial owners of the Voting Stock of the Corporation outstanding
immediately prior thereto continuing to beneficially own, directly or
indirectly (either by remaining outstanding or by being converted into
voting securities of the resulting entity), more than fifty percent of the
combined voting power of the voting securities of the Corporation or such
entity resulting from the transaction (including, without limitation, an
entity which as a result of such transaction owns the Corporation or all or
substantially all of the Corporation's property or assets, directly or
indirectly) outstanding immediately after such transaction in substantially
the same proportions relative to each other as their ownership immediately
prior to such transaction); or

c. the individuals who are Continuing Directors of the Corporation (as
defined below) cease for any reason to constitute at least a majority of
the Board of the Corporation.

The term "Continuing Director" means (i) any member of the Board who is a
member of the Board immediately after the 1999 annual meeting of shareholders,
or (ii) any person who subsequently becomes a member of the Board whose
nomination for election or election to the Board is recommended or approved by a
majority of the Continuing Directors. The term "Voting Stock" means all capital
stock of the Corporation which by its terms may be voted on all matters
submitted to shareholders of the Corporation generally.

ARTICLE XI -- AWARD AGREEMENTS

Awards may be evidenced by an agreement that sets forth the terms,
conditions and limitations of such Award. Such terms may include, but are not
limited to, the term of the Award, the provisions applicable in the event the
Participant's employment terminates, and the Corporation's authority to
unilaterally or bilaterally amend, modify, suspend, cancel or rescind any Award.
The Committee need not require the execution of any such agreement by a
Participant, in which case acceptance of the Award by the respective Participant
shall constitute agreement by the Participant to the terms of the Award.

ARTICLE XII -- AMENDMENTS

The Board may amend the Plan at any time as it deems necessary or
appropriate, subject to any requirement of shareholder approval required by
applicable law, rule or regulation, including Section 162(m) and Section 422 of
the Code, or any successor law; provided, however, that no amendment shall be
made without shareholder approval if such amendment would increase the maximum
number of Shares available under the Plan (subject to Article V(d)), or effect
any change inconsistent with Section 422 of the Code, or any successor law. No
amendment may impair the rights of a holder of an outstanding Award without the
consent of such holder. The Board may suspend the Plan or discontinue the Plan
at any time; provided, that no such action shall adversely affect any
outstanding Award.

ARTICLE XIII -- MISCELLANEOUS PROVISIONS

a. Employment Rights. The Plan does not constitute a contract of
employment and participation in the Plan will not give a Participant the right
to continue in the employ of the Corporation on a full-time, part-time,
E-7

or any other basis. Participation in the Plan will not give any Participant any
right or claim to any benefit under the Plan, unless such right or claim has
specifically accrued under the terms of the Plan.

b. Governing Law. Except to the extent superseded by the laws of the
United States, the laws of the State of New York, without regard to its conflict
of laws principles, shall govern in all matters relating to the Plan.

c. Severability. In the event any provision of the Plan shall be held to
be illegal or invalid for any reason, such illegality or invalidity shall not
affect the remaining parts of the Plan, and the Plan shall be construed and
enforced as if such illegal or invalid provisions had never been contained in
the Plan.

d. Withholding. The Corporation shall have the right to withhold from any
amounts payable under the Plan all federal, state, foreign, city and local taxes
as shall be legally required.

e. Effect on Other Plans or Agreements. Payments or benefits provided to a
Participant under any stock, deferred compensation, savings, retirement or other
employee benefit plan are governed solely by the terms of such plan.

f. Foreign Employees. Without amending the Plan, the Committee may grant
awards to eligible persons who are foreign nationals on such terms and
conditions different from those specified in the Plan as may, in the judgment of
the Committee, be necessary or desirable to foster and promote achievement of
the purposes of the Plan and, in furtherance of such purposes, the Committee may
make such modifications, amendments, procedures, subplans and the like as may be
necessary or advisable to comply with provisions of laws in other countries or
jurisdictions in which the Corporation or its subsidiaries operates or has
employees.

E-8

HEALTH MANAGEMENT SYSTEMS, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned appoints William F. Miller III and Philip Rydzewski,
and any one of them, as proxies, to vote all shares of Common Stock of Health
Management Systems, Inc. (the "Company") held of record by the undersigned as of
April 17, 2002, the record date with respect to this solicitation, at the Annual
Meeting of Shareholders of the Company to be held at 401 Park Avenue South, New
York, New York 10016 on Tuesday, June 4, 2002, at 11:00 A.M. and any
adjournments thereof, upon the following matters:

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED BY THE
UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED FOR
PROPOSALS 1, 2, 3 AND 4 ON THE REVERSE HEREOF. IF ANY NOMINEE DECLINES OR IS
UNABLE TO SERVE AS A DIRECTOR, THEN THE PERSONS NAMED AS PROXIES SHALL HAVE FULL
DISCRETION TO VOTE FOR ANY OTHER PERSON DESIGNATED BY THE BOARD OF DIRECTORS.

(OVER)

- --------------------------------------------------------------------------------
- FOLD AND DETACH HERE -

Please mark
your votes as
indicated in
this example [X]

1. ELECTION OF DIRECTORS:

FOR all nominees WITHHOLD
listed to the right AUTHORITY
(except as marked to the to vote for all nominees
contrary) listed to the right

[ ] [ ]

FOR AGAINST ABSTAIN

2. Ratification of award of options to purchase shares of HMSY Common Stock to
Mr. James T. Kelly. [ ] [ ] [ ]

FOR AGAINST ABSTAIN

3. Ratification of amendments to the Company's 1999 Long-Term Incentive Stock
Plan. [ ] [ ] [ ]

NOMINEES: 01 Randolph G. Brown, 02 James T. Kelly, 03 Galen D. Powers

- ---------------------------------------------
FOR, except for the following nominee(s)

4. Ratification of the selection of KPMG LLP as the Company's independent
accountants for the fiscal year ending December 31, 2002.

FOR AGAINST ABSTAIN

[ ] [ ] [ ]

5. To transact such other business as may properly come before the meeting
or any adjournment thereof.

SIGNATURE SIGNATURE DATE
------------------------------------ ------------------------------- ---------------

NOTE: PLEASE SIGN AS NAME APPEARS HEREON. JOINT OWNERS SHOULD EACH SIGN. WHEN
SIGNING AS ATTORNEY, EXECUTOR, ADMINISTRATOR, TRUSTEE OR GUARDIAN, PLEASE GIVE
FULL TITLE AS SUCH.

- --------------------------------------------------------------------------------
- FOLD AND DETACH HERE -

ANNUAL
MEETING OF
HEALTH MANAGEMENT SYSTEMS, INC. SHAREHOLDERS
JUNE 4, 2002
401 PARK AVENUE SOUTH
NEW YORK, NEW YORK 10016